COMMUNIQUÉS West-GlobeNewswire

aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update
06/11/2025
Results reported for Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis. Company plans to meet with the FDA to determine path forward for efzofitimod in pulmonary sarcoidosis in the first quarter of 2026. [...]
Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance
06/11/2025
-- Third quarter revenues up 6% driven by EXPAREL volume growth of 9% -- -- Several key milestones advance 5x30 path to growth and value creation -- -- Conference call today at 4:30 p.m. ET -- BRISBANE, Calif., Nov. 06 [...]
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
06/11/2025
Positive topline data from Part B of the TX45 Phase 1b trial demonstrated improvements in both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced [...]
Combined General Meeting of November 27, 2025 - Availability of the preparatory documents
06/11/2025
Daix (France), New York City (New York, United States), November 6, 2025 – Inventiva (Euronext Paris and Nasdaq : IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]
Assemblée Générale Mixte du 27 novembre 2025 - Modalités de mise à disposition des documents préparatoires
06/11/2025
Daix (France), New York City (New York, Etats-Unis), le 6 novembre 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Statement of total voting rights and shares forming the company’s share capital as October 20, 2025
06/11/2025
Article R. 22-10-23 of the French Commercial Code Market : Euronext Paris ISIN code / Mnemo : FR0013233012 / IVA Web site : www . i n v e n t i v a p ha r m a. c om Date Number of Shares Outstanding Total voting rights [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 20 octobre 2025
06/11/2025
Article R. 22-10-23 du Code de commerce Place de cotation : Euronext Paris Code ISIN / Mnémo : FR0013233012 / IVA Site web : www . i n v e n t i v a p ha r m a. c om Date Nombre de titres composant le capital en [...]
ORIC® Pharmaceuticals Announces Publication in Cancer Research on the Discovery and Development of Enozertinib, a Highly Selective, Brain-Penetrant EGFR Inhibitor
06/11/2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
06/11/2025
Presented new preclinical data on INB-619, a novel gamma-delta (γδ) T cell engager (TCE), demonstrating equivalent potency comparable to FDA-approved commercial products with minimal adverse cytokine release, [...]
Denali Therapeutics Announces Board and Executive Leadership Updates
06/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced updates to its Board of Directors and executive leadership team. Tim Van Hauwermeiren has been [...]
Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates
06/11/2025
Awaiting FDA clinical hold letter on MAGNITUDE and MAGNITUDE-2 clinical trials of nex-z Presenting longer-term Phase 1 clinical data of nex-z for ATTR-CM on November 10 at AHA 2025; previously published longer-term [...]
FDA Awards Second Batch of National Priority Vouchers
06/11/2025
Silver Spring, Md., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced six additional awardees under the Commissioner’s National Priority Voucher (CNPV) pilot program . This second [...]
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
06/11/2025
– Responsible for Corporate Development, Investor Relations, Government Affairs – REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today announced that Arvind Sood has [...]
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
06/11/2025
Obesity medicines coverage in U.S. Medicare Part D via a pilot programme, starting during 2026 Introduction of lower prices for Novo Nordisk’s semaglutide medicines in U.S. Medicare Part D and Medicaid and in direct-to- [...]
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution
06/11/2025
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution Paris, France (6 November 2025) – EssilorLuxottica today announced the [...]
EssilorLuxottica étend sa plateforme de solutions de gestion de la myopie avec les verres Essilor Stellest 2.0, des lunettes connectées et une solution innovante pour adresser la pré-myopie
06/11/2025
EssilorLuxottica étend sa plateforme de solutions de gestion de la myopie avec les verres Essilor Stellest 2.0, des lunettes connectées et une solution innovante pour adresser la pré-myopie Paris, France (6 novembre [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2025
06/11/2025
Aggregated presentation by day and by market Statement of transactions in own shares from October 27 th to October 31 st 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 44 - 2025
06/11/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 27 Octobre au 31 Octobre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
Corza Medical Launches Customer Portal to Enhance the Digital Ordering Experience for Eye Care Professionals
06/11/2025
PARSIPPANY, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a global medical technology company, today announced the launch of its new customer portal, now available to all its ophthalmology customers through [...]

Pages